- Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq
- The FDA just approved a revolutionary gene-modification treatmentQuartz
- Kite Nabs First Adult CAR-T Approval With Notable Uptick Of CuresXconomy
- UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
- Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post